26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan Lasse Leino, PhDChief Executive Officer, Adjunct Professor at DelSiTech Ltd.Speaker
Profile
Dr. Lasse Leino started his career in pharma industry almost for 20 years ago in Astra Zeneca in Sweden, moved then to Finland and had several managerial R&D positions in biotech and pharma companies. In 2005 he became a bio-entrepreneur and CEO of two drug development companies that were later merged and listed in the First North List in Helsinki Stock Exchange. Since 2013 he has been the Chief Executive Officer of a Finland-based drug delivery technology company DelSiTech Ltd. Dr. Leino has a PhD in biochemistry and holds also a position as Adjunct Professor at the University of Turku, Finland.
Agenda Sessions
Biodegradable Silica Composite Technology Enabling Long-Acting Controlled Release of GLP-1RAs
, 2:45pmView Session